Prosper Animal Health

Prosper Animal Health is a biotechnology company focused on developing a first-in-class transformative technology for vaccines and therapies for livestock and companion animals. Their core emphasis lies in a patented technology called IMT504, which is a novel oligodeoxynucleotide (ODN) with immunostimulatory effects. IMT504 activates key immune cells such as plasmacytoid dendritic cells, NK cells, NKT cells, and T and B cells, leading to the release of beneficial cytokines and robust antibody responses.

IMT504-based vaccines offer significant advantages over traditional animal vaccines, including unmatched efficacy, fast and sustained immune response, broader protection, and improved safety. These oil-free vaccines represent the next frontier in animal vaccines, ensuring healthier, more productive, and better-managed animals while requiring a reduced amount of antigen per dose. Prosper Animal Health's strategy involves developing, licensing, and commercializing this new class of oil-free vaccines and therapies based on the IMT504 technology.